NEXUS AG header image

NEXUS AG

NXU

Equity

ISIN DE0005220909 / Valor 1099292

Xetra (2025-11-24)
EUR 71.20-0.14%

NEXUS AG
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

NEXUS AG is a European company specializing in the development of innovative software solutions for the healthcare sector. Their product offerings include a clinical information system (NEXUS / KIS) and integrated diagnostic modules (NEXUS / DIS), designed to meet the wide-ranging functional requirements of hospitals, psychiatric institutions, rehabilitation, and diagnostic centers. The company focuses on creating user-friendly process support tools that enhance efficiency and safety in patient care. With over 250,000 daily users, including doctors, nurses, and administrative staff across various healthcare facilities, NEXUS AG emphasizes close customer relationships and localized support. Employing approximately 1,700 staff members, the company operates in seven European countries and serves clients in an additional 23 countries through certified dealers. NEXUS AG's growth is evidenced by its expanding customer base and consistently increasing revenues and profits.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

3.94%1Y
15.0%3Y
46.2%5Y

Performance

12.3%1Y
32.0%3Y
34.6%5Y

Volatility

Market cap

1415 M

Market cap (USD)

Daily traded volume (Shares)

150

Daily traded volume (Shares)

1 day high/low

69.6 / 68.7

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Axsome Therapeutics Inc
Axsome Therapeutics Inc Axsome Therapeutics Inc Valor: 30128285
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.80%USD 177.27
Prothena Corporation PLC
Prothena Corporation PLC Prothena Corporation PLC Valor: 20224443
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.97%USD 9.35
Mercury Systems Inc
Mercury Systems Inc Mercury Systems Inc Valor: 847694
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 103.02
Duolingo Inc
Duolingo Inc Duolingo Inc Valor: 112404331
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.76%USD 150.16
Immunocore Holdings PLC
Immunocore Holdings PLC Immunocore Holdings PLC Valor: 59524572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.83%USD 33.35
Blueprint Medicines Corp
Blueprint Medicines Corp Blueprint Medicines Corp Valor: 27670715
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 129.46
Flywire Corp
Flywire Corp Flywire Corp Valor: 111444572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.58%USD 13.79
Sportradar Group AG
Sportradar Group AG Sportradar Group AG Valor: 113423966
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.29%USD 18.97
Pacific Biosciences of California Inc
Pacific Biosciences of California Inc Pacific Biosciences of California Inc Valor: 11661709
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.96%USD 2.21
JFrog Ltd.
JFrog Ltd. JFrog Ltd. Valor: 56801627
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.93%USD 56.89